Interestingly, it was discovered that knockdown of METTL1 did not alter mRNA levels of cancer-related genes, but its translation efficiency was impaired, leading to a drop in cell cycle-related proteins such as CCNA2, CCND2, CDK6, CDK8 and EGFR, which affected tumor progression [71]. This evidence concerns the gene METTL1 and cancer.